Karyopharm Therapeutics – I have no work life balance day to day. End the work day earlier. | Comparably

Karyopharm Therapeutics – I have no work life balance day to day. End the work day earlier.

Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
Questa società sta accettando feedback da dipendenti verificate
DIPENDENTE
PARTECIPANTI
90
Nominale
Complessiva
2628

I have no work life balance day to day. End the work day earlier.

Other Employee Reviews for Karyopharm Therapeutics

Descrivere brevemente la vostra esperienza complessiva presso la vostra azienda
Descrivere brevemente la vostra esperienza complessiva presso la vostra azienda
Descrivere brevemente la vostra esperienza complessiva presso la vostra azienda
×
Rate your company